N-(3-((1H-pyrazol-3-yl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)-5-(pyridin-2-yl)thiophene-2-sulfonamide

ID: ALA1078492

PubChem CID: 45102707

Max Phase: Preclinical

Molecular Formula: C23H23N5O2S2

Molecular Weight: 465.60

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccc(-c2ccccn2)s1

Standard InChI:  InChI=1S/C23H23N5O2S2/c29-32(30,23-7-6-22(31-23)21-3-1-2-11-24-21)27-19-5-4-17-9-13-28(14-10-18(17)15-19)16-20-8-12-25-26-20/h1-8,11-12,15,27H,9-10,13-14,16H2,(H,25,26)

Standard InChI Key:  OSRBIQHRPHNLEN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   12.8065  -22.7987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8052  -23.6233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5156  -24.0348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5137  -22.3876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1470  -23.1855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7246  -22.3965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8890  -22.2551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7863  -23.9815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9451  -24.1817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2347  -23.6256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2291  -22.7948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0929  -24.0334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3818  -23.6212    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.7853  -22.9084    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.9634  -22.9084    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6665  -24.0273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0413  -23.1559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5145  -23.9155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2656  -24.7715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0039  -25.2772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7130  -24.7309    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.4127  -23.8879    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9968  -23.5423    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.3298  -24.0234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5810  -24.8062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4033  -24.8091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6165  -23.6147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6183  -22.7952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9059  -22.3867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1944  -22.7999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1996  -23.6261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9126  -24.0311    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  4  1  1  0
 13 16  1  0
  5 17  1  0
  5  6  1  0
 17 18  1  0
 18 19  1  0
  6  7  1  0
  5  8  1  0
  9 10  1  0
 10 11  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 18  2  0
 16 23  1  0
 11  7  1  0
  8  9  1  0
  2  3  1  0
  2 12  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 16  2  0
  3 10  2  0
 24 27  1  0
 12 13  1  0
 27 28  2  0
  1  2  2  0
 28 29  1  0
 13 14  2  0
 29 30  2  0
 11  4  2  0
 30 31  1  0
 13 15  2  0
 31 32  2  0
 32 27  1  0
M  END

Associated Targets(Human)

CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR6 Tchem Serotonin 6 (5-HT6) receptor (9749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GHSR Tclin Ghrelin receptor (6229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MLNR Tchem Motilin receptor (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Stomach (183 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 465.60Molecular Weight (Monoisotopic): 465.1293AlogP: 3.93#Rotatable Bonds: 6
Polar Surface Area: 90.98Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 6.29CX Basic pKa: 7.91CX LogP: 2.39CX LogD: 2.47
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -2.12

References

1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM..  (2009)  The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor.,  19  (22): [PMID:19804969] [10.1016/j.bmcl.2009.09.027]

Source